ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Combined Metagenomic Viral Detection and Donor-Derived Cell-Free DNA Quantification for Solid Organ Transplant Recipients

R. Sinha1, C. Rebello2, E. Bixler1, A. Al-Turck1, A. Berg1, J. Friedewald2, S. Kleiboeker1

1Eurofins Viracor, Lees Summit, MO, 2Northwestern University, Chicago, IL

Meeting: 2022 American Transplant Congress

Abstract number: 354

Keywords: Cytomeglovirus, Epstein-Barr virus (EBV), Infection, Polyma virus

Topic: Clinical Science » Infection Disease » 24 - All Infections (Excluding Kidney & Viral Hepatitis)

Session Information

Session Name: Transplant Infectious Diseases: All Organs

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 6, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 6:00pm-6:10pm

Location: Hynes Ballroom B

*Purpose: Solid organ transplant recipients are predisposed to opportunistic infections, and current viral diagnostic methods focus on sensitive detection of single pathogens by qPCR. However, a method that detects common viral pathogens with sensitivity and specificity comparable to current methods allows a comprehensive approach for detection.

*Methods: Whole-genome sequencing for donor-derived cell-free DNA (dd cfDNA), in which all cfDNA in a sample is sequenced, allows both quantification of % dd cfDNA and detection of viral DNA sequences from the same sample. A total of 605 plasma samples from 255 CTOT-08 subjects were analyzed for dd cfDNA by NGS as described (CJASN 16: 1539-1551, 2021). The NGS output files were further analyzed to provide read-assembly (contig) length and read depth for common DNA viruses. In this study, significant detections were defined as those from the Adenoviridae, Annelloviridae, Herpesviridae and Polyomaviridae with a contig lengths >150 bp.

*Results: Of the 605 samples tested, 188 (31.1%) yielded 257 viral detections from 137 subjects. Torque Teno virus was the most common detection (48.6%), followed by BK virus (BKV, 19.8%), cytomegalovirus (CMV, 10.9%) and Epstein Barr virus (EBV, 3.1%). Adenovirus, JC virus, human herpesvirus 6, herpes simplex virus 1/2, human polyomavirus 6 and human polyomavirus 8 all represented less than 2% of viruses detected. A subset of 40 samples was tested by BKV and CMV qPCR assays with 92.1% concordance to NGS results (78.1% positive agreement, 97.7% negative agreement). The mean dd cfDNA values differed significantly (P=0.0004, Mann Whitney test) between samples with viral detection (mean=0.64%, 95% CI=0.43-0.80%) compared to those without a viral detection (mean=0.97%, 95% CI=0.80-1.14%). Concordance of NGS and standard-of-care (SOC) diagnostic results was 84.6% (22 of 26 samples tested by both methods); however NGS detected 3 BKV, 3 CMV, and 2 EBV infections in samples drawn prior to SOC testing. Additionally, 4 BKV, 3 CMV, and 2 EBV infections with high viral loads were detected by NGS but not by SOC testing.

*Conclusions: In this retrospective study metagenomic viral detection combined with dd cfDNA quantification demonstrated sensitivity and concordance with qPCR while detecting some infections both earlier and when not identified by SOC testing. Prospective studies are needed to assess clinical utility.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Sinha R, Rebello C, Bixler E, Al-Turck A, Berg A, Friedewald J, Kleiboeker S. Combined Metagenomic Viral Detection and Donor-Derived Cell-Free DNA Quantification for Solid Organ Transplant Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/combined-metagenomic-viral-detection-and-donor-derived-cell-free-dna-quantification-for-solid-organ-transplant-recipients/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences